Davidson & Garrard’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$7.93M Sell
97,527
-3,979
-4% -$315K 1.87% 11
2017
Q2
$8.17M Sell
101,506
-2,679
-3% -$212K 1.95% 9
2017
Q1
$8.18M Sell
104,185
-571
-0.5% -$45.6K 1.95% 10
2016
Q4
$8.27M Buy
104,756
+4,955
+5% +$401K 2.05% 8
2016
Q3
$8.88M Buy
99,801
+496
+0.5% +$46.8K 2.21% 7
2016
Q2
$9.51M Sell
99,305
-286
-0.3% -$28.5K 2.34% 5
2016
Q1
$10.3M Sell
99,591
-1,217
-1% -$118K 2.64% 3
2015
Q4
$9.86M Buy
100,808
+872
+0.9% +$85.4K 2.45% 3
2015
Q3
$9.64M Sell
99,936
-730
-0.7% -$76.7K 2.5% 3
2015
Q2
$10.6M Sell
100,666
-2,886
-3% -$295K 2.45% 2
2015
Q1
$10.7M Sell
103,552
-4,382
-4% -$443K 2.44% 2
2014
Q4
$10.4M Sell
107,934
-2,881
-3% -$254K 2.41% 2
2014
Q3
$8.82M Sell
110,815
-203
-0.2% -$16K 2.14% 6
2014
Q2
$8.37M Sell
111,018
-717
-0.6% -$54.2K 2.01% 7
2014
Q1
$8.36M Sell
111,735
-2,463
-2% -$174K 2.08% 6
2013
Q4
$8.17M Buy
114,198
+154
+0.1% +$9.89K 2.07% 7
2013
Q3
$6.47M Sell
114,044
-3,015
-3% -$180K 1.82% 8
2013
Q2
$6.69M Buy
+117,059
New +$6.78M 1.99% 9

Other funds holding CVS

Davidson & Garrard's CVS Position: Q3 2017 in Review

Davidson & Garrard reduced its CVS Health (CVS) stake by 3.9% in Q3 2017, selling an estimated $315K and leaving 97,527 shares worth $7.93M. The position accounts for 1.87% of the portfolio, ranked #11.

Davidson & Garrard first reported a position in CVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $10.7M in Q1 2015. 1,531 funds tracked by Wall St. Rank hold CVS as of Q3 2017.

  • Davidson & Garrard held 97,527 shares of CVS Health worth $7.93M as of Q3 2017.
  • Davidson & Garrard sold 3,979 CVS Health shares in Q3 2017, an estimated $315K.
  • CVS Health made up 1.87% of Davidson & Garrard's portfolio in Q3 2017, its #11 holding.
  • Davidson & Garrard first reported a position in CVS Health in Q2 2013 and has held it in 18 quarters since.
  • Davidson & Garrard's CVS Health position peaked at $10.7M in Q1 2015.
  • 1,531 funds tracked by Wall St. Rank held CVS Health as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.